1253 Results

People

  1. Motzer
    Motzer
  2. Kingham
    Kingham
  3. Hudis
    Hudis
  4. Abou-Alfa
    Abou-Alfa
  5. Horwitz
    Horwitz
  6. Zelenetz
    Zelenetz
  7. Kris
    Kris
  8. Perales
    Perales
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)
  7. Population Sciences Research Program (170)
  8. Epidemiology and Biostatistics (122)
  9. Center for Pancreatic Cancer Research (110)
  10. Genitourinary Oncology Service (109)
  1. "multicenter study"
Formats
  1. Journal Article (1219)
  2. Research Letter (12)
  3. Conference Paper (7)
  4. Correspondence (6)
  5. Review (5)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)

More Groups

People
  1. Robert Motzer (47)
  2. T Peter Kingham (31)
  3. Clifford Hudis (19)
  4. Andrew Zelenetz (18)
  5. Ghassan Abou-Alfa (18)
  6. Steven Horwitz (18)

More People

Years
  1. 2025 (86)
  2. 2024 (191)
  3. 2023 (130)
  4. 2022 (83)
  5. 2021 (50)
  6. 2020 (63)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Lancet Oncology (57)
  3. New England Journal of Medicine (56)
  4. Clinical Cancer Research (46)
  5. Blood (44)
  6. Cancer (36)

More Publications

Publishers
  1. Elsevier Inc. (152)
  2. Elsevier Science, Inc. (137)
  3. American Society of Clinical Oncology (124)
  4. Springer (84)
  5. Oxford University Press (79)
  6. Wiley Blackwell (71)

More Publishers

Results (1253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Coping with glioblastoma: Prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists
    Journal Article

    Walsh, L. E.; Polacek, L. C.; Panageas, K.; Reiner, A.; Walbert, T.; Thomas, A. A.; Buthorn, J.; Sigler, A.; Prigerson, H. G.; Applebaum, A. J.; more...
    Journal of Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience
    Research Letter

    Mohan, M.; Becnel, M. R.; Shah, U. A.; Dong, H.; Gundarlapalli, S.; Peterson, T.; Orozco, J. S.; Horowitz, S.; Chhabra, S.; Dhakal, B.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: A multicentre, open-label, phase 2 study
    Journal Article

    Zauderer, M. G.; Szlosarek, P. W.; Le Moulec, S.; Popat, S.; Taylor, P.; Planchard, D.; Scherpereel, A.; Koczywas, M.; Forster, M.; Cameron, R. B.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • MATTERHORN: Phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
    Review

    Janjigian, Y. Y.; Van Cutsem, E.; Muro, K.; Wainberg, Z.; Al-Batran, S. E.; Hyung, W. J.; Molena, D.; Marcovitz, M.; Ruscica, D.; Robbins, S. H.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • A phase I study investigating AZD8186, a potent and selective inhibitor of PI3Kβ/δ, in patients with advanced solid tumors
    Journal Article

    Choudhury, A. D.; Higano, C. S.; de Bono, J. S.; Cook, N.; Rathkopf, D. E.; Wisinski, K. B.; Martin-Liberal, J.; Linch, M.; Heath, E. I.; Baird, R. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in solid tumors with defects in polymerase epsilon
    Journal Article

    Rousseau, B.; Bieche, I.; Pasmant, E.; Hamzaoui, N.; Leulliot, N.; Michon, L.; de Reynies, A.; Attignon, V.; Foote, M. B.; Masliah-Planchon, J.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib
    Journal Article

    Bauml, J. M.; Li, B. T.; Velcheti, V.; Govindan, R.; Curioni-Fontecedro, A.; Dooms, C.; Takahashi, T.; Duda, A. W.; Odegaard, J. I.; Cruz-Guilloty, F.; more...
    Lung Cancer (2022)

    Fulltext@MSK | Save
  • Bias in patient experience scores in radiation oncology: A multicenter retrospective analysis
    Journal Article

    Cha, E.; Mathis, N. J.; Joshi, H.; Sharma, S.; Zinovoy, M.; Ru, M.; Cahlon, O.; Gillespie, E. F.; Marshall, D. C.
    Journal of the American College of Radiology (2022)

    Fulltext@MSK | Save
  • Natural history and characteristics of ERBB2-mutated hormone receptor-positive metastatic breast cancer: A multi-institutional retrospective case-control study from AACR Project GENIE
    Journal Article

    LeNoue-Newton, M. L.; Chen, S. C.; Stricker, T.; Hyman, D. M.; Blauvelt, N.; Bedard, P. L.; Meric-Bernstam, F.; Punglia, R. S.; Schrag, D.; Lepisto, E. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save